glp-1/gip vs tirzepatide Structures of (a) GLP-1, (b) GIP and (c) [19, 88, 90] Semaglutide vs Tirzepatide Research Comparison

Monitoring protocol A structured approach to heart rate monitoring provides early warning if effects are trending toward concerning territory: Baseline measurement: Before starting retatrutide, measure resting heart rate for 5 consecutive mornings immediately upon waking (before getting out of bed, before coffee, before checking your phone)

Managing Side Effects: The 2026 Protocol While highly effective, semaglutide dosing can lead to temporary gastrointestinal issues

Retatrutide Dosing Schedule Chart Retartrutide VS

Summary: Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) that, based on Phase 2 trial data, produces significant appetite suppression and progressive weight loss, alongside gastrointestinal side effects that are most prominent during dose escalation

Regular monitoring with your doctor is recommended if you stay on it long term